OSA / SA hydrogel suitable for cell co-culture as well as preparation method and application of OSA / SA hydrogel
By using hydrogels prepared with specific proportions of oxidized alginate and alginate in cell coculture, the problems of difficulty in separation of matrix gel and insufficient modular assembly capabilities are solved, and easy separation of cells and tissue engineering of bones is achieved. Constructed to provide a flexible cell interaction research platform.
Patent Information
- Application Number
- CN202411009591.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-26
- Publication Date
- 2024-11-08
AI Technical Summary
In the existing cell co-culture methods, matric gel cannot be effectively isolated and does not have the ability to modular assembly, which affects the experimental results and the construction of tissue engineering bone.
Hydrogels are prepared using oxidized alginate (OSA) and alginate (SA) at a mass ratio of 0.7 to 1.5:1, and OSA/SA hydrocoagulation is prepared by sterilization treatment and crosslinking agents (such as calcium chloride). gel, realizes the isolation and modular assembly of different cells.
This method allows easy separation and assembly of different cells, solves the problems of difficulty in separation of matrix gel and insufficient modular assembly capabilities. It is suitable for cell co-culture and construction of tissue engineering bones, providing a more flexible and effective cell interaction research platform.
Smart Images

Figure CN118909317A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a hydrogel, and in particular to an OSA / SA hydrogel suitable for cell co-culture, and a preparation method and application thereof. Background Art
[0002] Bone tissue engineering refers to the process of separating autologous high-concentration osteoblasts, bone marrow stromal stem cells or chondrocytes, culturing and amplifying them in vitro, and then implanting them on a natural or synthetic cell scaffold or extracellular matrix that has good biocompatibility and can be gradually degraded and absorbed by the human body. This biomaterial scaffold can provide cells with a three-dimensional space for survival, which is beneficial for cells to obtain sufficient nutrients, exchange gases, and eliminate waste, allowing cells to grow on a prefabricated three-dimensional scaffold. This cell hybrid material is then implanted into the bone defect site. While the biomaterial is gradually degraded, the implanted bone cells continue to proliferate, thereby achieving the purpose of repairing bone tissue defects.
[0003] Cell co-culture refers to culturing two or more types of cells (from the same tissue or different tissues) in the same culture system. Cell co-culture technology can simulate the in vivo environment to a large extent, so as to better observe the interaction between cells and cells, cells and the culture environment, detect the relationship between different cytokines, and explore the mechanism of drug action and possible targets.
[0004] Existing cell co-culture methods include embedded cell co-culture method and multilayer matrix gel co-culture method, as follows:
[0005] (1) The embedded cell co-culture method, namely the Transwell chamber, is a type of permeable cup-shaped device. A permeable membrane is placed at the bottom of the cup. Generally, a polycarbonate membrane is used, and the pore size ranges from 0.1 to 12.0 μm. The Transwell chamber is placed in a culture plate. The inner chamber is called the upper chamber, and the inner chamber of the culture plate is called the lower chamber. Cell A is planted in the upper chamber, and the components in the culture fluid of cell B planted in the lower layer can affect cell A in the upper chamber, so that the effects of substances secreted or metabolized by cell B on the growth and movement of cell A can be studied. However, the material cost of the Transwell chamber is high, and the porous polycarbonate membrane of the Transwell chamber only allows the exchange of small molecules such as growth factors between cells; in addition, the Transwell chamber also requires the selection of pore size, and choosing the right pore size is crucial to the success of the experiment. If the pore size is not selected properly, it may affect the migration and invasion ability of the cells, thereby affecting the experimental results;
[0006] (2) Multilayer matrix gel co-culture method is a method for establishing 3D cell / organoid embedding culture. By mixing KemiGel matrix gel with enhanced system cell suspension at room temperature and transferring it to a culture plate, KemiGel can be coated into a thicker hydrogel at the bottom of the culture plate, and another type of cell can be directly inoculated on the upper surface of the hydrogel to form a multilayer cell structure to simulate the interaction between cells in vivo. This method allows cells to interact / immerse in the functional hydrogel and can well maintain their full contact with the upper culture medium. When cells migrate / aggregate on the surface of the hydrogel, cell clusters can be quickly formed (1 to 3 days). In addition, the multilayer matrix gel co-culture method can also be used to study intercellular communication, cell invasion, angiogenesis, immune co-culture, organoid interaction and other experiments. This strategy will provide a strong support system for life science research. However, the material cost used in this method is relatively high, the matrix gels of different cells cannot be effectively separated, and it does not have the ability of modular assembly, so it cannot be directly used to construct tissue engineering bone. Summary of the invention
[0007] The purpose of the present invention is to provide an OSA / SA hydrogel suitable for cell co-culture and a preparation method and application thereof, which solves the problem that the matrix glue used in the existing cell co-culture cannot be effectively separated and does not have the ability of modular assembly. The mechanical properties of the OSA / SA hydrogel used in the present invention are taken into account with the sterilization method, and different cells can be easily separated from each other, which is beneficial to operations such as separate detection of different cells.
[0008] In order to achieve the above object, the present invention provides an OSA / SA hydrogel suitable for cell co-culture, wherein the mass ratio of oxidized alginate OSA to alginate SA in the OSA / SA hydrogel is (0.7-1.5):1.
[0009] Preferably, the mass ratio of the oxidized alginate OSA to the alginate SA is 1:1.
[0010] Preferably, the oxidized alginate is selected from oxidized sodium alginate; the alginate is selected from sodium alginate; and the cross-linking agent used in the preparation of the OSA / SA hydrogel is selected from calcium salt.
[0011] Preferably, the calcium salt is selected from calcium chloride.
[0012] Preferably, the mass volume concentration of the calcium chloride is 1.2%.
[0013] Another object of the present invention is to provide a method for preparing the OSA / SA hydrogel, which comprises: dissolving oxidized alginate OSA and alginate SA in a mass ratio of (0.7 to 1.5):1 in water, sterilizing them, and cross-linking them with a cross-linking agent to obtain the OSA / SA hydrogel.
[0014] Preferably, the sterilization treatment uses a 0.22 μm filter; and the cross-linking agent is a calcium chloride aqueous solution with a mass volume concentration of 1.2%.
[0015] Another object of the present invention is to provide the use of the OSA / SA hydrogel in cell co-culture or construction of tissue engineering bone.
[0016] Preferably, the cell co-culture method comprises: mixing a cell with a sterile SA / OSA mixed solution, cross-linking with a cross-linking agent, and obtaining an OSA / SA hydrogel embedding the cell; cross-linking other cells that need to be co-cultured with the sterile SA / OSA mixed solution on the OSA / SA hydrogel embedding the cell as needed, and culturing the hydrogels in the same culture system;
[0017] Alternatively, the cell co-culture method comprises: mixing the cells to be co-cultured with a sterile SA / OSA mixed solution respectively, cross-linking with a cross-linking agent to obtain an OSA / SA hydrogel encapsulating each cell; and culturing the OSA / SA hydrogel encapsulating each cell in the same culture system as needed.
[0018] The preparation of the sterile SA / OSA mixed solution comprises: dissolving oxidized alginate OSA and alginate SA in a mass ratio of (0.7-1.5):1 in water, sterilizing the solution, and obtaining a sterile SA / OSA mixed solution.
[0019] Another object of the present invention is to provide a modularly assembled tissue engineering bone, which is obtained by co-culturing an OSA / SA hydrogel embedding cells with osteogenic differentiation function and an OSA / SA hydrogel embedding cells with immunomodulatory ability; the mass ratio of oxidized alginate OSA and alginate SA in the OSA / SA hydrogel is (0.7-1.5):1.
[0020] Preferably, the cells with osteogenic differentiation function are selected from 3T3 cells; the cells with immunomodulatory ability are selected from macrophages. In the present invention, 3T3 cells capable of osteogenic differentiation are selected, and OSA / SA hydrogel exists as a material scaffold. The three (growth factors, material scaffold, seed cells) constitute tissue engineering bone.
[0021] Another object of the present invention is to provide a method for constructing tissue-engineered bone, which comprises: dissolving oxidized alginate OSA and alginate SA in a mass ratio of (0.7 to 1.5):1 in water, sterilizing to obtain a sterile SA / OSA mixed solution; mixing cells with osteogenic differentiation function with the sterile SA / OSA mixed solution, cross-linking with a cross-linking agent to obtain an OSA / SA hydrogel embedding cells with osteogenic differentiation function; placing the OSA / SA hydrogel embedding cells with osteogenic differentiation function in a culture system, and then placing a culture vessel with a grid support at the bottom on the OSA / SA hydrogel embedding cells with osteogenic differentiation function, mixing cells with immunomodulatory ability with the sterile SA / OSA mixed solution in the culture vessel or adding them to the culture vessel after mixing, cross-linking with a cross-linking agent, culturing the two hydrogels in the same culture system, and constructing tissue-engineered bone;
[0022] Alternatively, the construction method comprises: dissolving oxidized alginate OSA and alginate SA in a mass ratio of (0.7 to 1.5):1 in water, sterilizing the solution, and obtaining a sterile SA / OSA mixed solution; mixing cells with osteogenic differentiation function and cells with immunomodulatory ability with the sterile SA / OSA mixed solution, respectively, cross-linking the cells with osteogenic differentiation function and obtaining OSA / SA hydrogels embedding cells with immunomodulatory ability and OSA / SA hydrogels embedding cells with immunomodulatory ability, respectively; placing the OSA / SA hydrogels embedding cells with osteogenic differentiation function and the OSA / SA hydrogels embedding cells with immunomodulatory ability in a culture system, culturing the two hydrogels in the same culture system, and constructing tissue engineered bone.
[0023] The present invention cross-links cells with immunomodulatory ability on OSA / SA hydrogels that embed cells with osteogenic differentiation function, so that the connection between the upper and lower layers is tighter and more seamless, which is more conducive to the exchange of substances.
[0024] Preferably, the OSA / SA hydrogel embedding cells with immunomodulatory ability is placed in the upper layer of the OSA / SA hydrogel embedding cells with osteogenic differentiation function for co-culture. The cells in the upper layer have immunomodulatory ability, which acts on the cells in the lower layer through the transmission of substances such as growth factors, which is more conducive to the contact between the cells in the lower layer and substances such as growth factors, and is conducive to immunomodulatory effects. Moreover, the OSA / SA hydrogel embedding cells with osteogenic differentiation function is placed in the lower layer to construct tissue engineering bone. During the detection stage, the upper layer hydrogel will be extracted and processed such as detection. There are changes in the environment during the operation, and the hydrogel in the lower layer has been in a relatively stable state and is less affected by environmental changes.
[0025] More preferably, the OSA / SA hydrogel embedding cells with immunomodulatory ability is placed in a culture vessel with a grid support at the bottom, and then placed on the upper layer of the OSA / SA hydrogel embedding cells with osteogenic differentiation function for co-culture.
[0026] Preferably, a cell suspension of cells having osteogenic differentiation function is mixed with the sterile SA / OSA mixed solution; and a cell suspension of cells having immunomodulatory ability is mixed with the sterile SA / OSA mixed solution.
[0027] More preferably, in a sterile environment, after the cells with immunomodulatory ability are cultured stably for more than 3 generations, they are made into a cell suspension of cells with immunomodulatory ability; after the cells with osteogenic differentiation function are cultured stably for more than 3 generations, they are made into a cell suspension of cells with osteogenic differentiation function.
[0028] More preferably, the cell culture conditions are: culture in an incubator at 37°C and 5% carbon dioxide concentration, using an α-MEM medium containing 10% fetal bovine serum (FBS) and 1% double antibody, and performing subculture at regular intervals.
[0029] The OSA / SA hydrogel suitable for cell co-culture and its application of the present invention have the following advantages:
[0030] (1) The method of the present invention solves the problem that hydrogel carriers embedding different cells in the same culture system in the multilayer matrix gel co-culture method cannot be easily separated and assembled. The OSA / SA hydrogel used in the method of the present invention uses an OSA / SA hydrogel prepared in a specific ratio to take into account both mechanical properties and sterilization methods, and can be sterilized by filtration. In addition, it can play a modular role, that is, different cells can be easily separated and combined, which is conducive to operations such as separate detection of different cells, and separation can be achieved in one go;
[0031] (2) The method of the present invention is simple to operate and has a variety of combinations. The hydrogel loaded with different cells is cross-linked to form a modular cell carrier. Using the hydrogel with good biocompatibility as a carrier, different cell carriers can be cultured in combination. The key lies in the construction method of OSA / SA hydrogel cell modules, the modularization of hydrogels by embedding cells in OSA / SA hydrogels, and the method of co-culturing different modules. The modular hydrogels can be assembled for co-culture, which expands the co-culture technology.
[0032] (3) The method of the present invention solves the problem that the material in the co-culture method cannot be directly used as a tissue engineering bone scaffold material after co-culture. The present invention uses OSA / SA hydrogel as a cell culture carrier, and loads two types of cells, macrophages and 3T3 cells, into the hydrogel and then cultured in the same culture system. It can be used to study the regulatory mechanism between cells, and can be used to construct tissue engineering bone with bone immune regulation. The present invention utilizes macrophage module culture to construct a cellular immune microenvironment, and then adds 3T3 cell modules for co-culture to construct tissue engineering bone. The combination of the two can directly construct tissue engineering bone with bone immune regulation. This is a co-culture technology, and at the same time, it realizes the construction of tissue engineering bone with bone immune regulation;
[0033] (4) The OSA / SA hydrogel used in the present invention has good biocompatibility, and cells embedded therein still have strong activity. The hydrogel has no adhesion sites, and cells can migrate and recruit therein. The hydrogel material cross-linked after loading different cells can be separated, which is convenient for achieving modular assembly requirements. Moreover, in the same culture system, growth factors and the like between different cells can be freely exchanged. The pores of the hydrogel allow growth factors and the like to pass through, which is convenient for constructing tissue engineering bone.
[0034] (5) The present invention solves the problem of selecting pore size in the embedded cell co-culture method. There is no need to select pore size. By embedding cells in the hydrogel of the present invention, various cells can exchange small molecules such as growth factors. Moreover, if macrophages are used in combination with 3T3 cells, tissue engineering bone can be directly constructed. BRIEF DESCRIPTION OF THE DRAWINGS
[0035] Figure 1 These are the performance analysis results of hydrogel modules with different ratios in Experimental Example 2 of the present invention.
[0036] Figure 2 These are the CCK8 experimental results of hydrogel modules with different ratios in Experimental Example 2 of the present invention.
[0037] Figure 3 The results are shown in Table 1. The results are a comparison of the adhesion between PVA-chitosan (CS) hydrogel and SA / OSA hydrogel in Experimental Example 3 of the present invention.
[0038] Figure 4 This is a graph showing the cell CCK8 detection results of Experimental Example 5 of the present invention.
[0039] Figure 5 This is the result of live or dead staining of 3T3 cells in Experimental Example 6 of the present invention.
[0040] Figure 6 This is the result of RAW cell live / death staining in Experimental Example 6 of the present invention. DETAILED DESCRIPTION
[0041] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0042] The inventors of the present invention have found in their research that the properties of SA / OSA (sodium alginate / oxidized sodium alginate) hydrogels with different ratios, including rheological properties, thermal stability, and deformation resistance, are different. Moreover, after the SA / OSA hydrogel prepared by the present invention is left to stand, the gap between the two hydrogels is still visible to the naked eye and can be easily separated using tools.
[0043] The present invention studies the biocompatibility of SA / OSA hydrogel and finds that it has good biocompatibility and can be used for cell culture. Therefore, the SA / OSA hydrogel of the present invention can be suitable for co-culture of cells. The amount of hydrogel and the number of embedded cells can be customized. If different volumes of tissue engineering bone need to be manufactured, the amount of hydrogel and the number of cells can be controlled according to the situation.
[0044] In addition, in the preparation of SA / OSA hydrogel, it was found that the use of different concentrations of CaCl2 aqueous solution for cross-linking would affect the cross-linking speed. Too high a concentration would make the hydrogel shape uneven, and too low a concentration would cause the hydrogel to take too long to gel. The 1.2% (w / v) CaCl2 aqueous solution had the most suitable gelling speed. Therefore, in the following experimental examples, a 1.2% (w / v) CaCl2 aqueous solution was selected for gelling.
[0045] The SA / OSA hydrogel provided by the present invention and the construction of modularly assembled tissue engineering bone are described in detail below through the experimental examples of the present invention.
[0046] Experimental Example 1 Construction of hydrogel modules
[0047] At room temperature, appropriate amounts of oxidized sodium alginate (OSA) and sodium alginate (SA) were weighed and mixed together in different mass ratios to set up three groups. The specific mixing ratios are as follows:
[0048] Group 1: OSA:SA = 1:1;
[0049] Group 2: OSA:SA=2:3;
[0050] Group 3: OSA:SA=3:2.
[0051] After ensuring that the three groups had the same mass, they were re-dissolved in UP water (ultrapure water) to make the weight of OSA / SA 2% of the weight of UP water, and sterilized through a 0.22 μm filter to obtain a sterile SA / OSA / UP water sterile mixed solution. At room temperature, a 1.2% (w / v) CaCl2 aqueous solution (as a cross-linking agent) prepared in UP water was used for cross-linking to obtain SA / OSA hydrogels with different mass ratios of 1:1, 2:3, and 3:2.
[0052] Experimental Example 2 Performance Analysis Experiment of Hydrogel Modules with Different Mass Ratios
[0053] 1. Experimental process
[0054] (1) Characterization of mechanical properties of hydrogels
[0055] Take an appropriate amount of the three mixed solutions prepared in the above experimental example 1 into a clean 24-well plate. The height of the solution should reach about 90% of the well plate. Use a syringe to slowly drip calcium chloride solution into the well until it is completely cross-linked. Take out the cylindrical long strip hydrogel, compress it, and test its mechanical properties. The measuring instrument is a universal mechanical testing machine with a measuring parameter of 1mm / min and a weighing element of 500N. After compressing the hydrogel cylinder to 90% of the initial height, draw its stress-strain curve.
[0056] (2) Characterization of rheological properties and stress relaxation properties of hydrogels
[0057] The rheological properties of the hydrogels were tested using a rheometer (MCR-302 rheometer, Anton Paar, The Republic of Austria) to evaluate the stress relaxation properties of the hydrogels, as follows:
[0058] Take appropriate amounts of the three mixed solutions prepared in Experimental Example 1 above and crosslink them in a clean 24-well plate to obtain gel discs with a diameter of 10 mm and a height of 1.5 mm, with 3 parallel samples in each group. Maintain a constant strain of 15%, and record the changes in the material's ability to resist load over time under the condition of maintaining a constant strain, so as to evaluate the relaxation characteristics of the material.
[0059] The rheological properties of the hydrogels were tested using a rheometer (MCR-302 rheometer, Anton Paar, The Republic of Austria), as follows:
[0060] Take appropriate amounts of the three groups of mixed solutions prepared in the above-mentioned Experimental Example 1 to a clean 24-well plate for cross-linking to obtain gel discs with a diameter of 10 mm and a height of 1.5 mm. Three parallel samples in each group were used to test the effect of frequency on the storage modulus (G') and loss modulus (G") of the gel, as well as the effect of temperature on the storage modulus (G') and loss modulus (G") of the gel, for a total of 18 samples.
[0061] The specific experimental parameters of the frequency test are: angular frequency 0.1 rad / s to 100 rad / s, constant room temperature 25° C., and shear strain set to 2%.
[0062] The specific experimental parameters of the temperature test are: temperature 15-45°C, constant frequency, and shear strain set to 2%.
[0063] (3) CCK8 experiment
[0064] The primary mouse mesenchymal stem cells (BM-MSCs) used were derived from the Biomaterial Center of Wangjiang Campus of Sichuan University. CCK8 experiments on BM-MSCs cells were conducted, in which SA / OSA hydrogels with different mass ratios of 1:1, 2:3, and 3:2 were co-cultured under the same conditions.
[0065] 2. Experimental results
[0066] (1) Results of rheological analysis of samples
[0067] like Figure 1 As shown in A, it is the effect of temperature change on the rheological properties of hydrogels with different mass ratios under fixed shear frequency. In the figure, G" is the energy dissipation modulus of the material, which is used to characterize the liquid-like behavior (viscosity) of the material, referring to the energy lost by the material during deformation; G' is the storage modulus of the material, which is used to characterize the solid-like behavior (elasticity) of the material. The ratio of the two is the loss coefficient of the material, reflecting the viscoelastic properties of the material. When the loss coefficient is 1, it means that the material is in a viscoelastic state, that is, a state of coexistence of solid and liquid; when the loss coefficient is greater than 1, the material is more inclined to a viscous state; when the loss coefficient is less than 1, the material is more inclined to an elastic state. The curve in the figure shows that the increase in temperature affects the internal structure of the material. As the temperature increases, the internal state of the material gradually becomes a viscous state. The more OSA accounts for, the more viscous the material is. When OSA:SA=3:2, the material loss coefficient rises rapidly with the increase in temperature, while the loss coefficient of the materials constructed with the ratio of OSA:SA=2:3 and OSA:SA=1:1 is relatively stable, indicating that excessive addition of OSA will affect the thermal stability of the material.
[0068] like Figure 1As shown in B, it is the rheological-frequency data of hydrogel matrices with different mass ratios constructed under a fixed external environment with frequencies from low to high. As can be seen from the figure, when the frequency gradually increases, the material properties do not change much, and the internal structure of the material does not undergo major damage. Compared with the OSA:SA=2:3 ratio, the hydrogels constructed with the OSA:SA=1:1 and OSA:SA=3:2 ratios are more viscous. In comparison, the OSA:SA=1:1 ratio has better elasticity, and the loss coefficient of the hydrogel constructed with the OSA:SA=2:3 ratio is close to 1, indicating that the hydrogel material constructed with this ratio is an elastic material.
[0069] (2) Results of stress relaxation test on samples
[0070] By applying a constant load to three hydrogel samples with different mass ratios, the load changes with time were recorded. Figure 1 As shown in C and D, C is the degree of hydrogel resistance to deformation under constant strain, and D is the time for the hydrogel to resist deformation to reach 1 / 2. The three materials have different stress relaxation performance parameters. The results show that the change in stress relaxation performance changes with the change in the proportion of OSA. In terms of resistance to deformation, the smaller the proportion of OSA, the better the mechanical properties of the material and the stronger the resistance to deformation. The fundamental reason for this trend change is that the OSA molecular chain changes, the molecular chains used for cross-linking are reduced, and the molecular weight of the cross-linked material is reduced, which affects the mechanical properties of the material. However, the larger the molecular weight obtained by cross-linking, the more difficult it is to filter the material, and other sterilization methods will affect the basic properties of the material.
[0071] (3) CCK8 experimental results
[0072] like Figure 2 As shown (D1: day 1; D3: day 3), the experimental results showed that the cells in the three groups of hydrogels with different proportions all showed proliferation activity, the cells had good activity and were able to be cultured.
[0073] Therefore, the present invention adopts an OSA:SA mass ratio of 1:1 to create a hydrogel module that takes both mechanical properties and sterilization methods into consideration.
[0074] Experimental Example 3 Adhesion Performance Comparison Experiment
[0075] 1. Preparation of PVA-CS hydrogel
[0076] Chitosan (CS) was added into UP water at a concentration of 2% by mass, and after being stirred evenly with a magnetic stirrer, glacial acetic acid was added at a concentration of 1% by mass, and stirring was continued until completely dissolved, and polyvinyl alcohol (PVA) was added at a concentration of 5% by mass, and heated and stirred at 90°C until completely dissolved, and placed in a clean bench to be cooled to obtain a PVA / CS mixed solution.
[0077] 20 mL of the above-mentioned PVA / CS mixed solution was thoroughly mixed with 200 μL of 1% concentration of genipin solution (as a cross-linking agent) and poured into a sterile mold. The mold was then placed in a sterile light-proof container and placed in a -20°C refrigerator. After repeated freezing and thawing three times, it was placed at room temperature for 3 days to obtain PVA-CS hydrogel.
[0078] 2. Comparative experiment
[0079] The adhesion of the PVA-CS hydrogel and the SA / OSA hydrogel with a mass ratio of OSA:SA of 1:1 prepared in Experimental Example 1 of the present invention were compared. Two hydrogels of the same type were overlapped and placed in a container. Figure 3 In A and B, A is PVA-chitosan hydrogel, and B is SA / OSA hydrogel. After a small amount of the crosslinking solution used in each preparation was added to the container, the hydrogels were placed in an environment at 37°C and allowed to stand for 24 hours. The adhesion of the overlapping parts of the two hydrogels was observed.
[0080] like Figure 3 As shown in C and D, C is the result after two PVA-chitosan hydrogels are adhered, and D is the result after two SA / OSA hydrogels are adhered. It can be seen that the PVA-CS hydrogel has been tightly adhered after 24 hours of standing and cannot be easily separated, similar to a layer cake. However, after the SA / OSA hydrogel in the present invention is left to stand, the gap between the two hydrogels is still visible to the naked eye and can be easily separated using tools. Therefore, it is shown that the OSA / SA hydrogel of the present invention can be easily separated and assembled during the culture process, and can be suitable for cell co-culture.
[0081] Experimental Example 4 Construction of modularly assembled tissue engineering bone
[0082] The above OSA / SA hydrogel is used to construct tissue engineering bone. In this experimental example, macrophages with immunomodulatory ability and 3T3 cells that can undergo osteogenic differentiation are used. OSA / SA hydrogels embedded with macrophages and OSA / SA hydrogels embedded with 3T3 cells are cultured in the same system. Substances with immunomodulatory ability secreted by macrophages, such as growth factors, are transferred to OSA / SA hydrogels embedded with 3T3 cells. The OSA / SA hydrogels embedded with 3T3 cells obtained by culture are tissue engineering bones with bone immunomodulation. Among them, 3T3 cells are seed cells, which are the basic cells for creating or repairing tissues, and OSA / SA hydrogels are used as material scaffolds, as follows:
[0083] (1) After macrophages were cultured stably for 3 generations or more under a sterile environment, they were made into macrophage (RAW) suspension; after 3T3 cells (MC3T3-E1 cells were used) were cultured stably for 3 generations or more, they were made into 3T3 cell suspension; the culture conditions of both cells were: cultured in an incubator at a temperature of 37°C and a carbon dioxide concentration of 5%, and the culture medium used was α-MEM medium containing 10% fetal bovine serum (FBS) and 1% double antibody, and the cells were subcultured every 48 hours;
[0084] (2) mixing one of the cell suspensions prepared in step (1) with a sterile SA / OSA / UP water sterile mixed solution with a ratio of OSA:SA of 1:1 prepared in Experimental Example 1, and cross-linking using a 1.2% (w / v) CaCl2 aqueous solution in Experimental Example 1 at room temperature to obtain a hydrogel encapsulating one cell;
[0085] (3) The hydrogel encapsulating one cell prepared in step (2) is placed at the bottom of the culture system, and then a culture vessel with a grid support at the bottom is placed on the hydrogel encapsulating one cell. Another cell suspension is mixed with the sterile SA / OSA solution prepared in step (2) in the culture vessel, and then a 1.2% (w / v) CaCl2 aqueous solution is used to embed the cells. After cross-linking is completed, the two hydrogels will be cultured in the same culture system, and the same culture conditions as in step (1) can be used to construct and obtain tissue engineered bone.
[0086] Due to the particularity of the SA / OSA hydrogel used in the present invention, when the two hydrogels are placed in the same culture system for culture, the two hydrogels will not adhere together and become unable to be separated, which is conducive to modular customization and separate detection of different cells.
[0087] Experimental Example 5 Cell Viability Detection
[0088] After the two cells in Experimental Example 4 were co-cultured for 3 days, the hydrogels encapsulating the respective cells were extracted for CCK8 detection.
[0089] like Figure 4 As shown, the results show that the cells in the hydrogel of the present invention have good cell viability and the overall trend is a proliferation state.
[0090] Experimental Example 6: Live and dead staining experiment
[0091] Good biocompatibility is the basis for hydrogels to be used for cell culture. The hydrogel modules encapsulating different cells in the same co-culture system in Experimental Example 4 of the present invention were subjected to live and dead staining.
[0092] Live-Dead Cell Staining is an experimental technique used to distinguish live cells from dead cells. It is mainly based on the difference in affinity between live cells and dead cells for specific dyes. It uses the dye to react specifically with different components in the cell, so that these components appear in different colors and forms under the microscope. Through this technique, live cells and dead cells, as well as the location and form of various structures in the cell such as the nucleus, chromosomes, and organelles, can be clearly observed. The cell membrane of live cells is intact and has selective permeability, which can control the entry and exit of substances in the cell. The cell membrane of dead cells is damaged and loses its integrity, allowing substances to enter and exit the cell freely. The dye will fluoresce at a specific wavelength. Live cell dyes usually emit green fluorescence, while dead cell dyes emit red fluorescence. This allows live and dead cells to be visually observed under a fluorescence microscope.
[0093] like Figure 5 As shown, the results of 3T3 cell death and viability staining in Experimental Example 6 of the present invention are as follows. Figure 6 As shown, the RAW cell live and dead staining results in Experimental Example 6 of the present invention, FDA is fluorescein diacetate, PI is propidium iodide, and by comparing the fluorescence staining on days 1 and 3, it was found that the number of both types of cells on the third day increased significantly and the live cells grew well, which shows that the hydrogel of the present invention has good biocompatibility.
[0094] Although the content of the present invention has been described in detail through the above preferred embodiments, it should be appreciated that the above description should not be considered as a limitation of the present invention. After reading the above content, it will be apparent to those skilled in the art that various modifications and substitutions of the present invention will occur. Therefore, the protection scope of the present invention should be limited by the appended claims.
Claims
1. An OSA / SA hydrogel suitable for cell co-culture, characterized in that: The mass ratio of oxidized alginate OSA to alginate SA in the OSA / SA hydrogel is (0.7-1.5):
1.
2. The OSA / SA hydrogel according to claim 1, characterized in that The oxidized alginate is selected from oxidized sodium alginate; the alginate is selected from sodium alginate; and the cross-linking agent used in the preparation of the OSA / SA hydrogel is selected from calcium salt.
3. The OSA / SA hydrogel according to claim 2, characterized in that The calcium salt is selected from calcium chloride.
4. The OSA / SA hydrogel according to claim 3, characterized in that The mass volume concentration of the calcium chloride is 1.2%.
5. The method for preparing the OSA / SA hydrogel according to claim 1, characterized in that: The method includes: Oxidized alginate OSA and alginate SA in a mass ratio of (0.7-1.5):1 are dissolved in water, sterilized, and cross-linked with a cross-linking agent to obtain the OSA / SA hydrogel.
6. The preparation method according to claim 5, characterized in that: The sterilization treatment uses a 0.22 μm filter; the cross-linking agent is a calcium chloride aqueous solution with a mass volume concentration of 1.2%.
7. Use of the OSA / SA hydrogel according to any one of claims 1 to 4 in cell co-culture or construction of tissue engineering bone.
8. A modularly assembled tissue engineering bone, characterized in that: The tissue engineering bone is obtained by co-culturing OSA / SA hydrogels embedding cells with osteogenic differentiation function and OSA / SA hydrogels embedding cells with immunomodulatory ability; The mass ratio of oxidized alginate OSA and alginate SA in OSA / SA hydrogel is (0.7~1.5):
1.
9. The tissue engineered bone according to claim 8, characterized in that: The cells with osteogenic differentiation function are selected from 3T3 cells; and the cells with immunoregulatory ability are selected from macrophages.
10. The method for constructing tissue engineering bone according to claim 8 or 9, characterized in that: The build method contains: Dissolve oxidized alginate OSA and alginate SA in water at a mass ratio of (0.7-1.5):1, sterilize, and obtain a sterile SA / OSA mixed solution; The cells with osteogenic differentiation function are mixed with the sterile SA / OSA mixed solution, and cross-linked with a cross-linking agent to obtain an OSA / SA hydrogel embedding the cells with osteogenic differentiation function; The OSA / SA hydrogel embedding cells with osteogenic differentiation function is placed in a culture system, and a culture vessel with a grid support at the bottom is placed on the OSA / SA hydrogel embedding cells with osteogenic differentiation function, and the cells with immunomodulatory ability and the sterile SA / OSA mixed solution are mixed in the culture vessel or added to the culture vessel after mixing, and cross-linked with a cross-linking agent, and the two hydrogels are cultured in the same culture system to construct tissue engineering bone; Or, the construction method contains: Dissolve oxidized alginate OSA and alginate SA in water at a mass ratio of (0.7-1.5):1, sterilize, and obtain a sterile SA / OSA mixed solution; The cells with osteogenic differentiation function and the cells with immunomodulatory ability are mixed with the sterile SA / OSA mixed solution respectively, and cross-linked with a cross-linking agent to obtain OSA / SA hydrogels embedding cells with osteogenic differentiation function and OSA / SA hydrogels embedding cells with immunomodulatory ability respectively; OSA / SA hydrogels encapsulating cells with osteogenic differentiation function and OSA / SA hydrogels encapsulating cells with immunomodulatory ability are placed in a culture system, and the two hydrogels are cultured in the same culture system to construct tissue-engineered bone.
